Vir Biotechnology, Inc.

NasdaqGS:VIR Stock Report

Market Cap: US$1.6b

Vir Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:VIR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Nov 25SellUS$37,782Jason O'ByrneIndividual6,799US$5.56
03 Nov 25SellUS$8,003Vanina de VerneuilIndividual1,365US$5.86
15 Jul 25SellUS$37,162Mark EisnerIndividual6,796US$5.47
03 Apr 25SellUS$474,239Marianne De BackerIndividual79,712US$5.95

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VIR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,0000.00626%
State or Government37,3930.0234%
Individual Insiders7,517,7424.7%
VC/PE Firms34,584,59421.6%
General Public36,435,88522.8%
Institutions81,225,78150.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.5%.

Top Shareholders

Top 25 shareholders own 62.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.2%
BlackRock, Inc.
16,330,103US$160.4m2.27%no data
8.21%
SB Investment Advisers (UK) Limited
13,116,977US$128.8m-21.4%0.84%
8.08%
Arch Venture Partners, L.P.
12,916,663US$126.8m0%9.25%
7.85%
The Vanguard Group, Inc.
12,548,944US$123.2m-1.96%no data
5.35%
GSK Equity Investments, Limited
8,550,954US$84.0m0%7.26%
3.9%
State Street Global Advisors, Inc.
6,229,555US$61.2m18.9%no data
2.36%
George Scangos
3,777,778US$37.1m0%no data
1.98%
FMR LLC
3,157,913US$31.0m-13.2%no data
1.59%
Dimensional Fund Advisors LP
2,536,277US$24.9m-14.9%no data
1.49%
OrbiMed Advisors LLC
2,380,715US$23.4m0%0.33%
1.46%
Geode Capital Management, LLC
2,328,207US$22.9m3.65%no data
1.3%
Morgan Stanley
2,070,940US$20.3m2.07%no data
0.94%
The Goldman Sachs Group, Inc.
1,496,442US$14.7m1.84%0.01%
0.87%
Aberdeen Group Plc
1,390,577US$13.7m-8.89%0.01%
0.86%
Balyasny Asset Management L.P.
1,368,474US$13.4m0%0.03%
0.83%
Hudson Bay Capital Management LP
1,325,000US$13.0m45.3%0.09%
0.71%
Vicki Sato
1,136,391US$11.2m-3.73%no data
0.67%
Marianne De Backer
1,073,822US$10.5m558%no data
0.65%
Candriam, Société En Commandite Par Actions
1,031,663US$10.1m0%0.03%
0.63%
Millennium Management LLC
1,002,606US$9.8m-28.2%0.01%
0.58%
GordonMD Global Investments LP
930,317US$9.1m0%6.52%
0.57%
Charles Schwab Investment Management, Inc.
904,499US$8.9m-20.9%no data
0.55%
Bank of America Corporation
878,700US$8.6m148%no data
0.53%
Northern Trust Global Investments
848,469US$8.3m-6.47%no data
0.46%
Columbia Management Investment Advisers, LLC
731,307US$7.2m276%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/12 19:31
End of Day Share Price 2026/03/12 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vir Biotechnology, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Huidong WangBarclays
Etzer DaroutBarclays